COMPARISON OF TREATMENT OF METASTATIC GASTROINTESTINAL CANCER WITH 5-FLUOROURACIL (5-FU) TO A COMBINATION OF 5-FU WITH CYTOSINE-ARABINOSIDE

被引：0
|
作者：
GAILANI, S
HOLLAND, JF
BURNINGHAM, R
LEONE, L
LARSEN, V
FALKSON, G
机构：
来源：
CANCER | 1972年 / 29卷 / 05期
关键词：
D O I：
10.1002/1097-0142(197205)29:5<1308::AID-CNCR2820290527>3.0.CO;2-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1308 / +
页数：1
相关论文
共 50 条
  • [1] METABOLISM OF 5-FLUOROURACIL (5-FU) IN HUMAN GASTROINTESTINAL CANCER
    BERNE, M
    ALMERSJO, O
    GUSTAVSSON, B
    [J]. ACTA CHIRURGICA SCANDINAVICA, 1983, : 31 - 31
  • [2] 5-FLUOROURACIL WITH CYTOSINE-ARABINOSIDE IN METASTATIC GASTROINTESTINAL CANCER
    MUSS, HB
    LOKICH, JJ
    FREI, E
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 18 (02) : 234 - 237
  • [3] 5-FLUOROURACIL (5-FU) IN THE TREATMENT OF PROSTATIC HYPERPLASIA
    WEI, XY
    ZHOU, XM
    [J]. UROLOGICAL RESEARCH, 1987, 15 (01): : 35 - 37
  • [4] Successful Treatment of Keloids with 5-Fluorouracil (5-FU)
    Weberschock, T.
    Podda, M.
    Rapprich, S.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 143 - 144
  • [5] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [6] 5-FLUOROURACIL (5-FU) PRESENTING AS A STEMI
    Okor, Ivana
    Ghosh, Priyanka
    Bhattarai, Shraddha
    Sattur, Sudhakar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3439 - 3439
  • [7] MITOMYCIN-C, 5-FU, AND CYTOSINE-ARABINOSIDE (MIFUCA) IN ADENOCARCINOMAS
    YAGODA, A
    LIPPMAN, A
    WINN, R
    ROSENBER.A
    SCHULMAN, P
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 190 - 190
  • [8] Photosensitivity due to 5-fluorouracil (5-FU)
    von Moos, R
    Sauter, C
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 129 (1-2) : 52 - 52
  • [9] Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
    Taïeb, J
    Artru, P
    Baujat, B
    Mabro, M
    Carola, E
    Maindrault, F
    Tournigand, C
    Krulik, M
    Louvet, C
    de Gramont, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 661 - 666
  • [10] TREATMENT OF EXPERIMENTAL ACUTE PANCREATITIS WITH 5-FLUOROURACIL (5-FU)
    JOHNSON, RM
    BARONE, RM
    NEWSON, BL
    DASGUPTA, TK
    NYHUS, LM
    [J]. AMERICAN JOURNAL OF SURGERY, 1973, 125 (02): : 211 - 222
12345